Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Precision Oncology
|
May 1, 2026
Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases
Cynthia Lilieholm, Adedamola O Adeniyi, Ohyun Kwon, et al.
Science Advances
|
June 4, 2025
Low-dose radiation by radiopharmaceutical therapy enhances GD2 <i>TRAC</i>-CAR T cell efficacy in localized neuroblastoma
Quaovi H Sodji, Amanda Shea, Dan Cappabianca, et al.
Neuro-Oncology
|
May 4, 2026
Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy
Lei Zhao, Paul A Clark, Jack M Shireman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2025
Enhanced Antitumor Efficacy of <sup>225</sup>Ac-NM600 Compared to <sup>177</sup>Lu-NM600 in Murine Prostate Cancer Models
Carolina A Ferreira, Hemanth K Potluri, Ahmed A Tantawy, et al.
Radiation (Multidisciplinary Digital Publishing Institute)
|
April 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors
Cynthia Lilieholm, Jen Zaborek, Ohyun Kwon, et al.
Radiation Research
|
March 25, 2026
Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs
Caroline P Kerr, Won Jong Jin, Alejandro J Oñate, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibition
Caroline P Kerr, Won Jong Jin, Peng Liu, et al.
Nature Communications
|
January 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice
Caroline P Kerr, Won Jong Jin, Peng Liu, et al.
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung Cancer
Rachel L Minne, Jayden L West, Natalie Y Luo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Precision Oncology
|
May 1, 2026
Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases
Cynthia Lilieholm, Adedamola O Adeniyi, Ohyun Kwon, et al.
Science Advances
|
June 4, 2025
Low-dose radiation by radiopharmaceutical therapy enhances GD2 <i>TRAC</i>-CAR T cell efficacy in localized neuroblastoma
Quaovi H Sodji, Amanda Shea, Dan Cappabianca, et al.
Neuro-Oncology
|
May 4, 2026
Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy
Lei Zhao, Paul A Clark, Jack M Shireman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2025
Enhanced Antitumor Efficacy of <sup>225</sup>Ac-NM600 Compared to <sup>177</sup>Lu-NM600 in Murine Prostate Cancer Models
Carolina A Ferreira, Hemanth K Potluri, Ahmed A Tantawy, et al.
Radiation (Multidisciplinary Digital Publishing Institute)
|
April 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors
Cynthia Lilieholm, Jen Zaborek, Ohyun Kwon, et al.
Radiation Research
|
March 25, 2026
Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs
Caroline P Kerr, Won Jong Jin, Alejandro J Oñate, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibition
Caroline P Kerr, Won Jong Jin, Peng Liu, et al.
Nature Communications
|
January 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice
Caroline P Kerr, Won Jong Jin, Peng Liu, et al.
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung Cancer
Rachel L Minne, Jayden L West, Natalie Y Luo, et al.
Page
of 2